Back to Awarded Treatment Trials
Awarded Trial: 13T-002
Grant ID
13T-002
Illness
schizophrenia
Primary Drug/Intervention
Nicotinic allosteric modulator
Primary Dosage
200 mg/day
Secondary Drug Intervention
Nicotine patch
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
Davidson
Sample Size
80
Duration of Study Period for Each Subject
28 days
Outcome Measurements
N/A
Results
N/A
Publication
N/A
Link
N/A
PI Name
Michael Davidson
Degree
MD
Center
N/A
Institution
CTR
Address
Popa Nun 115
City or Town
Bucharest
State or Province
N/A
Zip or Postal Code
30583
Country
Romania
Email Address
mdavidson6@gmail.com